Trending

Featured

April 23, 2024

Incyte to Acquire Escient Pharmaceuticals

WILMINGTON, Del. & SAN DIEGO--(BUSINESS WIRE)--Incyte (Nasdaq:INCY) and Escient Pharmaceuticals, a clinical-stage... Read more »

March 19, 2024

Rapport Therapeutics Appoints John Maraganore to Board of Directors

BOSTON & SAN DIEGO--(BUSINESS WIRE)--Rapport Therapeutics, Inc., a clinical-stage biotechnology company leveraging... Read more »

March 7, 2024

Johnson & Johnson Completes Ambrx Acquisition

NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) announced today it has successfully completed... Read more »

citybiz
Gain exposure through our multi-channel news platform.
For AgenciesFor Enterprise
April 15, 2024

Hammerspace Expands Support for Commodity Hardware in the Global Data Environment

April 11, 2024

Q&A with Joe Vezzani, CEO and Co-Founder of LunarCrush

April 9, 2024

2024’s Best & Worst States for Children’s Health Care – WalletHub Study

April 9, 2024

Amazon: Let Your Winners Run

April 4, 2024

Trump Media & Technology Group: Just Keep Selling

April 3, 2024

Maverix Medical Acquires Cirrus Bio

April 3, 2024

Amazon: Coming To Appreciate The Best Business In The World

April 3, 2024

Intel Faces A Massive Labor Cost Headwind

April 2, 2024

Intel: Laying Groundwork For Strong Share Price Upside

April 2, 2024

A16Z GAMES Opens Applications For Third SPEEDRUN Tech x Games Accelerator

April 1, 2024

Healthiest Cities in America (2024 Rankings) – WalletHub Study

March 28, 2024

Palo Alto Networks Is Overvalued, But Its Operations Are Compelling

March 27, 2024

Micron Will Experience Strong Tailwinds As GPU Capacity Loosens Up

March 26, 2024

Gilead Sciences Acquires CymaBay, For Approximately $4.3 Billion

March 21, 2024

Magnachip Semiconductor Corp Is A Hold Opportunity While Insiders Buy

March 21, 2024

Ocugen: A Speculative Buy In Biotech Growing Clinical Trials To Billion-Dollar Revenues